Issue Date: November 14, 2011
Drug Approvals Are Up In 2011
The Food & Drug Administration approved 35 new medicines in fiscal 2011, which ended on Sept. 30. The agency is using the result, the second-highest total in the past 10 years, to argue for renewal of the Prescription Drug User Fee Act (PDUFA), which authorizes the agency to collect user fees from industry to fund the drug approval process.
FDA released the results on Nov. 3 with fanfare that included a press conference . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society